While Puerto Rico’s academic institutions count with their own research infrastructures and resources, we understand that there is a need for a fresh, innovative update to these. Furthermore, there are limited opportunities outside of academic institutions for researchers to expand their horizons, take their scientific efforts out of academia and enter the Biotechnology industry. We are a Biotechnology and Life Sciences incubator underway to stand as a beacon of innovation, dedicated to fortifying Puerto Rico’s position as a vibrant hub for groundbreaking advancements. Our mission is clear; to catalyze the growth of research-driven initiatives and contribute significantly to Puerto Rico’s research landscape. By providing state-of-the-art facilities, fostering interdisciplinary collaborations, and offering strategic mentorship, we aim to drive economic growth, attract professional talents, create high-impact opportunities, and fortify Puerto Rico as a global leader in the life sciences and technology arena. Our vision is ambitious yet attainable; to fuel the growth of research-driven initiatives that not only drive economic prosperity but also elevate Puerto Rico to the forefront of global leadership in life sciences and technology. Our offerings are designed to support our companies at every stage of their journey, from having a physical address, incorporating their company, lab space rental and equipment access to mentorship, funding assistance, and industry partnerships. With a comprehensive suite of products and services, we aim to foster a thriving ecosystem of innovation, collaboration, and growth within the life sciences and biotechnology community. Our company’s value proposition commits to enabling an innovative approach to access to infrastructure and resources to academic institutions, researchers, startup companies, high school students and different private sectors such as pharmaceutical and medical devices companies, encouraging collaboration, economic and social development while growing the Bio-Science landscape in Puerto Rico. In summary, our incubator represents a bold step forward for Puerto Rico, offering a pathway to a sustainable and prosperous future built on the foundation of scientific excellence, collaboration, and innovation. We are committed to driving positive change and positioning Puerto Rico as a global leader in translational research.
Amgen
Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2025, Amgen was named to Fortune’s list of the World’s Most Admired Companies. | Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. A biotechnology pioneer since 1980, Amgen has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. | Biotech | x | Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen was named one of the “World’s Most Innovative Companies” by Fast Company and one of “America’s Best Large Employers” by Forbes. | Our mission is to serve patients. Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
AGMI Group
AGMI Group is a global advisory and execution firm specializing in strategy and operations for life sciences and healthcare companies. With deep roots in biopharma, medtech, and diagnostics, we partner with industry leaders, venture-backed innovators, and private capital to drive value across R&D, commercialization, and investment cycles. Founded by a team of ex-McKinsey and industry executives, AGMI combines strategic rigor with hands-on execution, focusing on four core areas: 1. R&D Portfolio Strategy & IND Readiness (Preclinical to Translational) 2. Commercial and Go-to-Market Strategy 3. Private Capital – Due Diligence & Equity Story Development 4. Operational Excellence & PMO Execution AGMI Group operates globally with hubs in Boston, Silicon Valley, and Puerto Rico, supporting clients across the U.S., LATAM, Japan, and Southeast Asia. Our team includes MDs, PhDs, and operators who bridge science and strategy, execution and insight—driving results where it matters most.
AbbVie
AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. Please visit us at www.abbvie.com | Allergan, an AbbVie company, has dedicated 75 years to advancing eye care, launching 125+ products for prevalent eye conditions. We continue our commitment to helping ECPs deliver superior patient care through R&D, outreach programs, and educational support. | x | AbbVie is a global, research-based biopharmaceutical company that focuses on addressing complex and serious health issues. It develops innovative therapies and harnesses the power of advanced science to improve patients’ lives across a range of therapeutic areas including immunology, oncology, neuroscience, eye care, virology, and women’s health. Established as an independent entity in 2013 following its separation from Abbott Laboratories, AbbVie now operates in over 175 countries with a commitment to discover and deliver transformative solutions to the global community. With tens of thousands of employees, AbbVie strives to foster an inclusive and diverse work environment, adhering to its core values of agility, accountability, smart decision-making, and courageous communication. | AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn. | AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas. For more information about AbbVie, please visit us at www.abbvie.com. | We are AbbVie. A global Fortune 100 biopharmaceutical company creating life-changing medicines and first-in-kind solutions that make a real difference in people’s lives. Our 50,000+ employees across geographies, disciplines, and therapeutic areas put impact at the core of every decision. Leading with purpose, we work to build a more sustainable future for generations to come. Inclusive. Collaborative. Innovative. Since day one our inclusive culture has been the secret to our success. It’s reflected in everything we do and everything we offer. | AbbVie’s mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas. For more information about AbbVie, please visit us at www.abbvie.com.
Abartys Health
Abartys Health has built a secure, privacy-compliant platform to improve healthcare data interoperability between clinical laboratories, patients, providers, and health insurance plans. We have established partnerships with the major lab information systems, including connections to over 800 clinical laboratories in Puerto Rico, and in 2023 expanded this model successfully to the Dominican Republic, Mexico, and US markets. We transform disparate sources into standardized, research-ready, actionable data by applying AI/ machine learning algorithms. We provide access on a subscription basis to Abartys’ ClinicLynk Insights Dashboards, with visualizations of nearly real-time lab results that describe the current epidemiology of chronic and infectious diseases. Dashboards are customizable to clients’ needs for academic research, population management insights, research, intervention, gaps in care, and clinical trial recruitment.